276 related articles for article (PubMed ID: 29925593)
21. Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.
Korkmaz B; Lesner A; Guarino C; Wysocka M; Kellenberger C; Watier H; Specks U; Gauthier F; Jenne DE
Pharmacol Rev; 2016 Jul; 68(3):603-30. PubMed ID: 27329045
[TBL] [Abstract][Full Text] [Related]
22. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
23. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
[TBL] [Abstract][Full Text] [Related]
24. BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis.
Kreideweiss S; Schänzle G; Schnapp G; Vintonyak V; Grundl MA
Inflamm Res; 2023 Aug; 72(8):1709-1717. PubMed ID: 37542002
[TBL] [Abstract][Full Text] [Related]
25. Membrane expression of proteinase 3 is genetically determined.
Schreiber A; Busjahn A; Luft FC; Kettritz R
J Am Soc Nephrol; 2003 Jan; 14(1):68-75. PubMed ID: 12506139
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
[TBL] [Abstract][Full Text] [Related]
27. Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles.
Martin KR; Kantari-Mimoun C; Yin M; Pederzoli-Ribeil M; Angelot-Delettre F; Ceroi A; Grauffel C; Benhamou M; Reuter N; Saas P; Frachet P; Boulanger CM; Witko-Sarsat V
J Biol Chem; 2016 May; 291(20):10476-89. PubMed ID: 26961880
[TBL] [Abstract][Full Text] [Related]
28. Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation.
Gabillet J; Millet A; Pederzoli-Ribeil M; Tacnet-Delorme P; Guillevin L; Mouthon L; Frachet P; Witko-Sarsat V
J Immunol; 2012 Sep; 189(5):2574-83. PubMed ID: 22844112
[TBL] [Abstract][Full Text] [Related]
29. Cathepsin C role in inflammatory gastroenterological, renal, rheumatic, and pulmonary disorders.
Aghdassi AA; Pham C; Zierke L; Mariaule V; Korkmaz B; Rhimi M
Biochimie; 2024 Jan; 216():175-180. PubMed ID: 37758158
[TBL] [Abstract][Full Text] [Related]
30. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
[TBL] [Abstract][Full Text] [Related]
31. Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies.
Surmiak M; Kaczor M; Sanak M
J Physiol Pharmacol; 2012 Jun; 63(3):249-56. PubMed ID: 22791638
[TBL] [Abstract][Full Text] [Related]
32. Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis.
Hinkofer LC; Hummel AM; Stone JH; Hoffman GS; Merkel PA; Spiera ER; St Clair W; McCune JW; Davis JC; Specks U; Jenne DE
J Autoimmun; 2015 May; 59():43-52. PubMed ID: 25744251
[TBL] [Abstract][Full Text] [Related]
33. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
35. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis.
Millet A; Martin KR; Bonnefoy F; Saas P; Mocek J; Alkan M; Terrier B; Kerstein A; Tamassia N; Satyanarayanan SK; Ariel A; Ribeil JA; Guillevin L; Cassatella MA; Mueller A; Thieblemont N; Lamprecht P; Mouthon L; Perruche S; Witko-Sarsat V
J Clin Invest; 2015 Nov; 125(11):4107-21. PubMed ID: 26436651
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic targeting of cathepsin C: from pathophysiology to treatment.
Korkmaz B; Caughey GH; Chapple I; Gauthier F; Hirschfeld J; Jenne DE; Kettritz R; Lalmanach G; Lamort AS; Lauritzen C; Łȩgowska M; Lesner A; Marchand-Adam S; McKaig SJ; Moss C; Pedersen J; Roberts H; Schreiber A; Seren S; Thakker NS
Pharmacol Ther; 2018 Oct; 190():202-236. PubMed ID: 29842917
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody (MCPR3-7) interfering with the activity of proteinase 3 by an allosteric mechanism.
Hinkofer LC; Seidel SA; Korkmaz B; Silva F; Hummel AM; Braun D; Jenne DE; Specks U
J Biol Chem; 2013 Sep; 288(37):26635-48. PubMed ID: 23902773
[TBL] [Abstract][Full Text] [Related]
38. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans.
Pham CT; Ivanovich JL; Raptis SZ; Zehnbauer B; Ley TJ
J Immunol; 2004 Dec; 173(12):7277-81. PubMed ID: 15585850
[TBL] [Abstract][Full Text] [Related]
39. Induction of proteinase 3-anti-neutrophil cytoplasmic autoantibodies by proteinase 3-homologous bacterial protease in mice.
Kim YC; Choi YS; Alam J; Kim YJ; Baek KJ; Koh J; Song YW; Chung DH; Choi Y
Immunol Res; 2016 Apr; 64(2):438-44. PubMed ID: 26318749
[TBL] [Abstract][Full Text] [Related]
40. Granulomatosis with polyangiitis (Wegener granulomatosis): A proteinase-3 driven disease?
Witko-Sarsat V; Thieblemont N
Joint Bone Spine; 2018 Mar; 85(2):185-189. PubMed ID: 28495524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
